Live Breaking News & Updates on Clinical Trials Career Development Program

Stay updated with breaking news from Clinical trials career development program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lyra sinks as rhinosinusitis drug-device misses in phase III

Less than a week ago, executives at Lyra Therapeutics Inc. were looking ahead to “imminent” data from its first phase III study in chronic rhinosinusitis (CRS), testing drug-device candidate LYR-210, a drug-device candidate largely expected to fill a much-needed gap in CRS treatment. On Monday, May 6, they were announcing plans to preserve cash in the wake of the failed Enlighten 1 study, which raised doubts as to the feasibility of the company’s CRS programs, which also include the similarly designed candidate LYR-220. ....

Lyra Therapeutics Inc , Lyra Therapeutics , Lyr 220 , Lyra Therapeutics Inc , Bioworld Medtech , Combination Drug Device , Lyr 210 , Mometasone Furoate , Chronic Rhinosinusitis ,

Breast Cancer Screening age extension welcomed by Waikato surgeon

The Government recently announced steps towards extending free breast cancer screening to women aged 70-74. Clinical lead for BreastScreen Aotearoa, Dr Adam. ....

New Zealand , United Kingdom , Danielle Zollickhofer , Valda Ritchie , Breastscreen Aotearoa , Shane Reti , Adam Stewart , Waikato Herald , Health New Zealand , Breastscreen Aotearoa Dr Adam , Minister Dr Shane Reti ,